Avantor, Inc. (AVTR)
- Previous Close
25.64 - Open
25.69 - Bid 25.46 x 1100
- Ask 25.46 x 1800
- Day's Range
25.06 - 26.20 - 52 Week Range
16.63 - 28.00 - Volume
5,127,881 - Avg. Volume
8,724,312 - Market Cap (intraday)
17.363B - Beta (5Y Monthly) 1.33
- PE Ratio (TTM)
49.12 - EPS (TTM)
0.52 - Earnings Date Oct 25, 2024 - Oct 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
27.79
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
www.avantorsciences.com14,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: AVTR
View MorePerformance Overview: AVTR
Trailing total returns as of 9/6/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AVTR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AVTR
View MoreValuation Measures
Market Cap
17.36B
Enterprise Value
22.21B
Trailing P/E
49.12
Forward P/E
20.75
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.55
Price/Book (mrq)
3.19
Enterprise Value/Revenue
3.25
Enterprise Value/EBITDA
19.92
Financial Highlights
Profitability and Income Statement
Profit Margin
5.28%
Return on Assets (ttm)
3.67%
Return on Equity (ttm)
6.90%
Revenue (ttm)
6.83B
Net Income Avi to Common (ttm)
360.2M
Diluted EPS (ttm)
0.52
Balance Sheet and Cash Flow
Total Cash (mrq)
287.5M
Total Debt/Equity (mrq)
94.11%
Levered Free Cash Flow (ttm)
708.61M